We have developed a panel of 14 monoclonal antibodies (MAbs) to POL, the catalytic subunit of herpes simplex virus type 1 (HSV-1) DNA polymerase encoded by gene UL30, and one HAb to the UL52 protein, another of the seven proteins essential for replication of HSV DNA. The approximate locations of the epitopes of the polymerase-specific MAbs were identified using truncated polymerase molecules, and the antibodies were characterized in a number of immunological assays allowing eight different specificities to be recognized. These MAbs, together with a polyclonal antibody raised in rabbits against a third DNA replication protein, ICP8, were used to localize the respective proteins by immunofluorescence in cells infected with wild-type HSV-1 or the DNA replication-defective mutants ombUL8 or 2-2. In BHK cells infected with ambULS, a mutant with an amber termination codon within the coding region of gene UL8, the UL52 protein did not enter the nucleus, although ICP8 and POL entered the nucleus in a normal fashion. The failure of the UL52 protein to be correctly transported to the nucleus was also observed in both HFL and Vero cells infected with ambUL8. In contrast, UL52 protein was transported to the nucleus in BHK cells infected with wild-type HSV-1 or with 2-2, a mutant lacking a functional UL9 protein.
Introduction
Herpes simplex virus type 1 (HSV-1) encodes seven proteins that are essential for origin-dependent viral DNA synthesis and three origins of replication (Stow, 1982; Weller et aI., 1985; Wu eta] ., 1988). The UL9 product is an originbinding protein (OBP), the UL29 product (ICPS) is a singlestranded DNA binding protein while the UL30 protein (POL) and UL42 proteins are the catalytic and accessory components respectively of a dimeric DNA polymerase (reviewed by Challberg, 1991; Weller, 1991) . The remaining three proteins, ULS, UL8 and UL52, form a trimeric complex that exhibits both DNA helicase and DNA primase activities (Dodson eta] ., 1989; Crute et a] ., 1989). Although none of these three proteins alone exhibits appreciable enzymic activity, the UL5 and UL52 proteins can form a stable subassembly that retains both helicase and primase activities (Calder & Stow, 1990; Crute et al., 1991) . The presence of conserved helicase motifs within the UL5 protein that are necessary for HSV-1 replication suggests that this protein is largely responsible for DNA helicase activity (Gorbalenya et aI., 1989; Zhu & Weller, 1992) , whilst site-directed mutagenesis experiments have demonstrated that UL52 protein contributes an essential role in DNA priming (Klinedinst & Challberg, 1994; Dracheva et al., 1995) . UL8 protein within the complex has auxiliary effects on the DNA primase, stimulating either primer synthesis or utilization on a natural-sequence single-stranded DNA template (Sherman et al., 1992; Tenney et aI., 1994) , and a role in stabilizing primer-template interactions has been suggested.
Other activities of the UL8 protein have also been reported. These include a functional interaction with ICP8 in stimulating primer synthesis and a physical interaction with the origin-binding protein (McLean et al., I994) . Finally, a series of immunofluorescence experiments have shown that the presence of UL8 protein is necessary for efficient nuclear IP: 54.70.40.11
On: Wed, 21 Nov 2018 21:35:37 localization of the helicase-primase complex (Calder et al., 1992) . In these studies additional copies of the ULS, UL8 and UL52 proteins were expressed under the control of the HSV-I immediate early (IE) 3 gene promoter by an HSV-1 mutant, tsK, which contains a temperature sensitive lesion in the IE3 gene and as a consequence expresses IE proteins at high levels in the absence of viral early and late gene products. Mixed infections at the non-permissive temperature using viruses expressing the ULS, UL8 and UL52 proteins in various combinations revealed that co-expression of all three proteins is required for any of them to be efficiently transported into the cell nucleus. However, it has not been determined whether a similar situation pertains during the normal course of HSV-1 infection when all seven replication proteins are synthesized, a functional IE3 product is produced and the remaining IE proteins are not expressed at elevated levels.
In this study we used an HSV-1 UL8 mutant (ambUL8; Dargan et al., 1995; Patel et aI., 1996b) that specifies a truncated inactive version of the UL8 protein to provide further evidence that functional UL8 protein is required for the normal nuclear localization of the UL52 protein. MonocIonal antibodies (MAbs) reactive with the POL and UL52 proteins were developed which, together with a polyclonal antiserum against UL29, enabled the locations of the UL52, UL30 and UL29 proteins to be compared by immunofluorescence in cells infected with wt HSV-1, mutant ambUL8 and also a host range mutant (2-2) that lacks a functional UL9 product.
Methods
• Cells. Baby hamster kidney (BHK) cells were grown in Glasgow MEM with 10 % newborn calf serum, antibiotics (penicillin/streptomycin) and tryptose phosphate broth. Human fetal lung (HFL) cells were grown in the same medium as BHK cells with the addition of sodium pyruvate and non-essential amino acids. Veto cells were grown in Dulbecco's MEM with 10% newborn calf serum, glutamine and antibiotics. SP2/0-Ag14 myeloma (SP2) cells were grown in Dulbecco's MEM with 15 % fetal calf serum, 8 mM-glutamine, antibiotics and gentamicin. P3-X67-Ag8 myeloma (P3) cells were grown in Dulbecco's MEM with 10% fetal calf serum, 10 % horse serum, 8 mM-glutamine and gentamicin. Spodoptera frugiperda (St') cells were grown at 28 aC in TC100 medium with 5 % heatinactivated fetal calf serum, antibiotics and neomycin. All reagents were supplied by Gibco/BRL and used as recommended by the suppliers except where noted.
• Viruses. The wild-type (wt) HSV-1 strain used in these studies was 17 syn + (Brown et a]., 1973) . Mutant virus ambUL8, which contains a translational stop signal at codon 267 of the UL8 open reading frame that renders the protein inactive, was propagated on a Veto-derived cell line, A26, which expresses HSV-I genes ULS-UL10 (Dargan el al.,1995 ; Patel et al., 1996b) . Reconstituted wt virus ambUL8R (Pate [ et al., 1996b) was isolated by marker rescue of ambUL8. Mutant virus 2-2 is a spontaneous mutant that grows in A26 cells but not in Vero cells or in the Veroderived cell line G33, which expresses gene UL6, or the BHK-derived cell line B21, which expresses genes UL6-UL8 (Patel et al., 1996a) . These growth characteristics indicate that the mutation in 2-2 is in gene UL9 or UL10. Two separate findings indicate that the defect is in the UL9 gene.
First, in non-permissive cells, in contrast to the wt virus, the mutant did not replicate viral DNA and did not induce detectable levels of UL9 protein as judged by immunofluorescence using a UL9-specific MAb (unpublished data), Second, UL10 is not essential for virus growth in tissue culture (Baines& Roizman, 1991; MacLean et al., 1991) . The recombinant Autographa californica nuclear polyhedrosis viruses AcRP231acZ (parental virus), AcUL8, AcUL29, AcUL30 and AcUL52 have been described (Possee & Howard, 1987; Stow, 1992) .
• Production and purification of proteins. POL and ICP8 were extracted (Gottlieb et al., 1990) from Sf cells infected with recombinant baculoviruses AcUL30 and AcUL29 respectively. POL protein was purified by a modification of the procedure described by Gottlieb et al. (I990) . ICP8 was purified by single-stranded DNA-affinity chromatography as a first step (Gottlieb et al., 1990 ) using DNA-cellulose rather than DNA-agarose, and for the second step a method using mono Q chromatography was developed. Briefly, proteins were applied to a 15 ml DNA~ellulose column and eluted with a 150 ml linear gradient of 0"1-1"5 M-NaC1 . Fractions containing 1CP8 were pooled, dialysed against buffer C (Gottlieb et al., 1990) containing 50 mM-NaC1, applied to a I ml mono Q column and bound proteins were eluted with a 15 m[ linear gradient of 0'05--0"5 M-NaCI in buffer C.
DNA fragments encoding portions of POL were subcloned from plasmid pE30 which encodes the full-length protein (Stow, 1993) . Convenient restriction endonuclease fragments of the UL30 gene were purified and inserted in-frame into the appropriate vector from the pQE30, pQE31, pQE32 series (Qiagen). The resulting plasmids specify fusion proteins with an N-terminal extension of approximately 25 aa, including a stretch of six histidine residues. E. colt strain XL-1 Blue cells (Stratagene) transformed with the following plasmids were used: pPQ223 encoding aa 1-212 (fragment I), pPQ101 encoding aa 162-316 (fragment 2), pPQ3 encoding aa 308--658 (fragment 3), pPQII7 encoding aa 597-975 (fragment 4), pPQ24 encoding aa 875-1119 (fragment 5), pPQ136 encoding aa I072-I145 (fragment 6) and pPQ131 encoding aa 1128-1235 (fragment 7). XL-1 Blue ceils transformed with the vector pQE32 served as a control. Fragments encoding aa 155-538, 539-983 and 766--1058 of the UL52 protein were similarly cloned in-frame using the same vectors to generate plasmids priG5, priG7 and priG9, respectively, which were expressed in E. colt strain TG1. Synthesis of the UL30 and UL52 fragments was induced following treatment of E. colt cultures with IPTG (optimum conditions were 0-1-1"0 mM-IPTG for 1-5 h depending on the construct). The pHG5 product was solubilized in 6 M-guanidinium chloride, bound to nickel-NTA-agarose (Qiagen) and eluted with 8 M-urea. The resulting preparation was approximately 90 % pure.
• Preparation of antibodies. Donor mice for MAb production received three subcutaneous injections at weekly intervals, the first with complete Freund's adjuvant (CFA) and the next two with incomplete Freund's adjuvant (IFA). Three to five weeks later the mice were boosted with antigen in PBS intraperitoneally and test bled. Spleen donors received a further boost with antigen intraperitoneally 4 days before the fusion. Mouse spleen cells were fused to P3 cells in the UL30 fusion or to SP2 cells in the UL52 fusion using polyethylene glycol 1000. Fused cells were plated at 3 x 105 cells per well in selective medium containing HAT. Purified UL30 protein was used both for immunizing donor mice and for assaying antibodies by ELISA. For production of UL52 MAbs, donor mice were immunized with the purified HG5 fragment and secreted antibodies were assayed by ELISA using extracts of Sf cells infected with either AcUL52 or the parental AcRP23IacZ. The amount of protein for each of the three initial immunizations was 10 lag for POL and 12 lag for the HG5 fragment, while for the boosts, 20 lag of POL and 118 lag of the HG5 fragment were used. ELISA assays for mouse antibodies were performed with the spent medium of growing hybridoma cells or with immunoglobulin (Ig) purified from it. Purification was achieved by precipitation of the Ig with ammonium sulphate at 50 % saturation or by a more rigorous procedure whereby the medium was delipidated with Cab-o-sil (BDH) followed by ammonium sulphate precipitation. Finally, the precipitate was dissolved in and dialysed against 20 raM-sodium phosphate buffer pH 7'0, and further purified using a protein G-Superose column (Pharmacia): bound Ig was eluted with 0-1 M-glycine pH 2"7, neutralized, aliquoted and stored frozen. Polyclonal antisera 514 and 515, specifc for the POL and ICP8 proteins respectively, were raised in rabbits by five intramuscular injections at fortnightly intervals, each of 5 ~tg of the appropriate purified protein. The first immunization was in CFA while subsequent immunizations were in IFA.
• ELISA. Plates were coated at 37 °C overnight with 0"25 ~tg per well of purified UL30 protein: an amount chosen by initial checkerboard titrations. Tissue culture supernatants were added for I h at room temperature. Bound antibodies were detected with horseradish peroxidase (HRP) coupled to anti-mouse Ig (Scottish Antibody Production Unit), and the chromogenic substrate ABTS (Sigma). For UL52-ELISAs, proteins in Sf cells infected with AcUL52 or AcRP23/acZ were solubilized in denaturing sample buffer (2% SDS, 5% 2-mercaptoethanol, 20% glycerol, 0"0125 M-Tris-HC1, pH 6'8, and bromophenoI blue) and then coated on microtitre wells.
• Western blots. Infected cells were solubilized with denaturing sample buffer and proteins were separated by I7'5 % SDS--PAGE and transferred to nitrocellulose membranes. The membranes were incubated with purified Ig, and bound Ig was visualized using HRP coupled to antimouse Ig for MAbs or protein A for rabbit antibodies (both Sigma), and chromogenic substrate 4-chloro-l-naphthol (Bio-Rad). Molecular masses were estimated by comparison with standard markers (Amersham, 46--2"35 kDa).
• Immunoprecipitation. Sf cells were infected with recombinant virus AcUL30 (Stow, 1992) or parental virus AcRP231acZ (Possee & Howard, 1987) , and incubated at 28 °C overnight. Infected cells were labelled with 100 rtCi/ml [35S]methionine (Amersham) from 24-31 h post-infection (p.i.). They were then washed and solubilized in extraction buffer (0"5% NP40, 0"5% sodium deoxycholate, 10% glycerol, 0"1 MTris-HC1, pH 8) for 1 h on ice. Hybridoma supematant (50 ~tl) was incubated overnight at 4 °C with 20 rtl of asS-labeUed extract and 5 lal of sheep anti-mouse Ig. Complexes were precipitated with protein ,4.-Sepharose, eluted by boiling with elution buffer (2% SDS, 5% 2-mercaptoethanol, 20% glycerol, 0'125 M-Tris-HCl, pH 6"8, bromophenol blue) and separated by 5-12"5 % gradient SDS--PAGE.
• Immunofluorescence. BHK cells grown on coverslips were infected with approximately 5 p.f.u, per cell. At 5 h p.i. cells were fixed in 2 % paraformaldehyde and permeabilized with 0"5 % NP40. Coverslips were incubated first with the POL-specific MAb 13429 (undiluted supernatant), or the UL52-specific MAb 14462 (ammonium sulphate precipitated Ig, diluted tenfold), or the ICP8-specific rabbit polydonal antiserum 515 and then incubated with anti-mouse Ig conjugated to FITC, and examined under a Nikon microphot-SA microscope.
• POL/UL42 interaction assays. The physical interaction assay was performed in microtitre wells coated with pol using MAb ZIFII !24~ (Schenk et al., 1988) to detect UL42 protein binding as described 
Results

Isolation and characterization of POL-specific MAbs
Fourteen hybridoma lines were developed that secreted antibodies which bound specifically to purified POL coated onto microtitre plates. These antibodies were tested for reactivity in immunoprecipitation, immunofluorescence and Western blotting assays and the findings are summarized in Table 1 . Eight of the 14 MAbs were positive in immunoprecipitation assays and reacted with a single major protein of the size expected for intact POL (data not shown). Of the four MAbs that were positive in immunofluorescence assays, the most strongly reactive was 13429. Eight MAbs were positive by Western blotting. Three MAbs (13185, 13429 and 13628) were reactive in all of the immunological assays.
The epitopes on POL recognized by those MAbs that reacted on Western blots were mapped using a series of seven fragments of gene UL30 that spanned the entire open reading frame. The fragments, designated 1-7, contained POL residues 1-212, 162-316, 308-658, 597-975, 875-1119, 1072-1145 and 1128-1235, and 
Lack of effect of POL-specific MAbs on the POL/UL42 interaction
None of the MAbs inhibited either the POL/UL42 physical interaction or the stimulation of polymerase activity by UL42 protein (data not shown). The experiments were performed under conditions in which inhibition could be demonstrated using peptides from the C terminus of POL or rabbit polyclonal antisera specific for the C terminus of POL .
Isolation and characterization of a UL52-specific MAb
A fragment of UL52 protein, encompassing aa 155-538, was used to immunize donor mice. Antibodies from one hybridoma line, 14462, reacted by ELISA with extracts from Sf cells infected with AcUL52 but not the parental virus AcRP231acZ. MAb 14462 reacted on Western blots of extracts of AcUL52-infected Sf cells (Fig. 2 , lane 2) with a band (upper arrow) that comigrated with the UL52 protein (data not shown). As expected, it reacted with the aa 155-538 fragment priG5 (lane 4, lower arrow) that had been used to generate the antibody but did not react with fragments pHG7 (aa 559-983) or pHG9 (aa 766-1058) or the vector pQ31. MAb 14462 also stained HSV-infected ceils in an immunofluorescence assay.
Localization of the UL52 protein in cells infected with a UL8-defective virus
Antigens were detected by indirect immunofluorescence in BHK-21 cells fixed with paraformaldehyde and permeabilized with 0"5 % NP40. The distribution of the ICP8, POL and UL52 proteins was visualized with rabbit polyclonal antiserum 515, MAb 13429 and MAb 14462 respectively and the cells shown are representative of those observed. Background fuorescence of mock-infected cells was minimal with all antibodies (Fig.  3 A, B, C) . In BHK cells, 5 h after infection with wt virus, all the antibodies stained nuclear structures. Both POL-and ICP8-specific antibodies stained most of the nucleus (Fig. 3E, F) . UL52-staining, although confined to the nucleus, was morphologically distinct from that of POL and ICP8: it was less widespread and covered one or a few large lobe-like structures (Fig. 3 D) . In BHK cells infected with the ambUL8 mutant, the UL52-specific MAb did not show specific nuclear fluorescence: instead, the whole cell was stained (Fig 3 G) . In contrast, both POL and ICP8 entered the nucleus normally (Fig, 3 H, I ). To investigate whether another DNA replication defective mutant not affected in the helicase-primase complex blocked transport of the UL52 protein to the nucleus, cells were infected with the UL9-defective virus 2-2. All three proteins entered the nucleus normally (Fig. 3J, K, L) , but again the distribution of UL52 differed in detail from that of POL and ICP8. Specifically, several areas, possibly nucleoli, were not stained. (Fig. 3 J) .
To establish rigorously that the failure of the UL52 protein to be transported to the nucleus was due to the absence of a functional UL8 protein rather than some secondary mutation in ambUL8 outwith the UL8 gene, the localization of the UL52 protein was examined in cells infected with the reconstituted wt virus ambUL8R (Patel eta] ., 1996 b). UL52 protein localizes normally to the nucleus of cells infected with the reconstituted wt and parental wt viruses (Fig. 4 C and A, respectively) , but not the ULS-defective virus (Fig. 4 B) .
To investigate whether the observed protein distributions were unique to BHK cells, the effect of the absence of UL8 protein on the localization of UL52 protein was examined in HFL and Vero cells. In all three cell types infected with wt 124( virus, the UL52 protein localized to specific areas ot the nucleus, again giving a loI2e like or gloI2ular appearance (Fig.  5 A, C and E). HFL and BHK cells infected with ambUL8 were stained h o m o g e n e o u s l y w i t h the ULSZ-specific M A b (Fig.   5 D, B) . In V e r o ceIIs infected w i t h ambULS, a l t h o u g h the r~uorescence was cytoplasmic in most ceils (Fig. 5 F) , there was evidence for preferential nuclear localization in 1 0 -2 0 % of the cells (Fig. 5 G) . Thus, in HFL cells and in the majority of Veto cells, the distribution of UL52 in the absence of functional UL8 was like that found in BHK ceils, that is UL52 did not enter the nucleus normally. In the few Vero cells in which UL52 protein had been transported into the nucleus in the absence of UL8 protein, its distribution was not lobe-like as observed in cells infected with wt virus.
Discussion
To our knowledge, this is the first report describing the isolation and characterization of MAbs specific for the POL and ULS2 proteins of HSV. Within the i4 MAbs specific for the catalytic subunit of the DNA polymerase, eight distinct specificikies can be recognized. This can be deduced from the data in Table 1 , which show that six distinct patterns of reactivities (A F) in immunofluorescence (IF), immunoprecipitation (IP) and Western blotting (WB) assays were observed. Pattern A, represented by MAbs 13185, 13429 and 113625, is formed by those MAbs that are positive in all three assays. It contains two specificities: MAbs 13185 and 1342,9 recognize an epitope between aa 9 7 6 -I 0 7 1 whereas the epitope recognized by MAb 13628 lies between aa i i 2 0 -li27. Similarly, MAbs 13129, 13488 and 13528, constituting pattern B, define two epitopes. For UL52, only a single MAb was isolated that reacts with a fragment-containing aa I55-538.
None of the POL-specific antibodies inhibited DNA polymerase activity or interfered with the physical or functional interaction between POL and its accessory protein UL42. The nine different epitopes recognized by the antibodies are widely spread over POL though none is located near its C terminus. These findings are consistent with our earlier observation that the C-terminal 27 aa of POL are responsible for at least 75 % of the binding energy of POL to UL42 protein. Interestingly, of the panel of 13 UL42-specific MAbs that was i iiiiiiiiiiiiiiiiiiiiiiiiiiiiii iiii iiii iiii aiiii iiiiiii!iii!iiiiii recently described by Scheaffer et al. (1995) , all but one of the epitopes were outside the minimal active portion of the protein and none interfered with the POL/UL42 interaction. The authors made the analogous conclusion that their results were consistent with structure-function studies on the UL42 protein.
The POL-and UL52-specific MAbs, and other previously described antibodies, were used to show that UL8 was necessary for transportation of UL52, but not POL and ICP8, into the nucleus of ceils infected with wt HSV (Fig. 3) . Mutant 2-2, defective in expressing UL9, another of the proteins essential for virus DNA replication, served as a control to show that lack of transportation of UL52 protein to the nucleus was not a general feature of DNA replication deficient virus. These observations extend the earlier findings of Calder et al. (1992) , made with UL8 and UL52 proteins expressed at high level in cells in the absence of early and late viral proteins, to cells in which synthesis of the other replication proteins is not blocked. They further support the observation that efficient nuclear localization of the components of the helicase-primase complex requires co-expression of the three subunits (Calder et al., 1992) . In the absence of functional UL9 protein, the UL52 protein was excluded from certain regions of the nucleus (Fig.  3) . The nature of these regions has not yet been investigated but we are inclined to think they could be nucleoli or disaggregating nucleoli.
The effect of individual mutations in each of the seven essential DNA replication proteins on the distribution of ICP8 and POL in infected cells has been examined (Lukonis & Weller, 1996; Liptak et al., 1996) in order to determine the requirement for each of the seven proteins in the assembly of the viral DNA prereplicative site structures (Quinlan et aI., 1994) and the localization of replication proteins to these sites. Lukonis & Weller (1996) also showed that the UL5, UL8 and UL52 proteins colocalized with ICP29 within the DNA replication compartments that form in the nucleus of cells during a permissive infection. In the latter experiments, cells were transfected with plasmids that express the UL5, UL8 and UL52 proteins at high levels from the strong ICP6 (UL39) promoter upon superinfection with viruses carrying null mutations in each of these three genes. In the experiments we describe in this paper, the UL5, UL8 and UL52 proteins were expressed at normal levels from their own promoter. Our aim was to determine only whether the UL52 protein was found in the nucleus or cytoplasm of virus-infected cells and did not extend to examining the fine structure of the localization of UL52 within the nucleus. It may be that the UL52-specific antibody (MAb 14462) will be sufficiently sensitive to allow colocalization studies at the low levels of UL52 protein found in wt virus-infected cells but that possibility remains to be tested with confocal microscopy and dual antibody labelling. In any event, the antibodies that we have described here will be useful tools with which to further study the interactions made by POL and UL52 protein in the organization of the HSV DNA replication complex.
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